Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Search

Māori and Pacific governance

Māori and Pacific governance groups discuss and inform study protocols and issues that have arisen during the study, particularly those pertaining to Māori and Pacific ARF patients and their whānau.

News & Events

Hep C can be cured, but many people are still not being treated

People living with hepatitis C in WA are being urged to take part in a new project, aimed at encouraging the take-up of treatment. 

Travel Scholarships

Thank you to our Sponsors Contact us If you'd like to get in touch, please contact Marie Nadal-Sims by phone or email. Phone: (08) 6319 1001 Email:

Meningococcal studies

Contact us If you'd like to get in touch, please contact us by phone or email. Phone: 0400 450 240 Email: vtg@thekids.org.au Meningococcus (Neisseria

2017 Round 2 Seed Funding Recipients

The Wesfarmers Centre is pleased to announce the successful applications for the 2017 Round 2 Wesfarmers Centre Seed Funding. The Wesfarmers Centre

2015 Seed Funding Recipients

Eight applicants were successful, and were awarded $15,000 each for activities supporting subsequent research grant applications.

2014 Seed Funding Recipients

In 2014, the Wesfarmers Centre of Vaccines & Infectious Diseases put out a first call for seed funding proposals.

National Healthy Skin Guideline

National Healthy Skin Guideline: for the Prevention, Treatment and Public Health Control of Impetigo, Scabies, Crusted Scabies and Tinea for Indigenous Populations and Communities in Australia

Spritz-OM

Preventing over half of the world’s ear infections with a therapy such as Spritz-OM will significantly improve health and educational outcomes on a global scale.

Research

A Systematic Framework for Prioritizing Burden of Disease Data Required for Vaccine Development and Implementation: The Case for Group A Streptococcal Diseases

Vaccine development and implementation decisions need to be guided by accurate and robust burden of disease data. We developed an innovative systematic framework outlining the properties of such data that are needed to advance vaccine development and evaluation, and prioritize research and surveillance activities.